#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive multifocal leukoencephalopathy Congenital pseudarthrosis Chronic myeloid leukaemia (in remission) Spina bifida Immune-mediated renal disorder Carcinoid tumour Iron overload Cardiac sarcoidosis Anaplastic thyroid cancer Chronic myeloid leukaemia Ovarian epithelial cancer Mantle cell lymphoma stage IV Oesophageal adenocarcinoma stage II Marginal zone lymphoma refractory Primitive neuroectodermal tumour More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma – Life with Disease Mucopolysaccharidosis II Congenital hypotransferrinaemia Primary immunodeficiency syndrome Haemophilia B with anti factor IX – Basic Information Fabry’s disease – Life with Disease Haemophilia B with anti factor IX Glomerulonephritis membranous – Treatment Marginal zone lymphoma – Trials in Disease Haemophilia A without inhibitors – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Buserelin Acetate Afamitresgene Autoleucel Obexelimab Azd3427 LY4170156 SKB410 D-Camphor Azd8630 Cefazolin Sodium Munc-T3 Dexrazoxane SAR443820 Ict01 Moxifloxacin Flortaucipir (18F) Voxelotor Dacarbazine Goserelin Isavuconazonium Sulfate Tinzaparin Sodium More therapies…

    Learn about Your Condition

    Metastatic glioma Eosinophilic oesophagitis Colon cancer metastatic Vaginal cancer Primary hypogonadism Femoral neck fracture Oral neoplasm Myopia Diabetic foot Prostatitis Escherichia coli Short stature Type 1 diabetes mellitus Cutaneous calcification Synovitis Renal cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Adagrasib
    • Pembrolizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Study of Avapritinib for Adults with Systemic Mastocytosis Who Previously Participated in an Avapritinib Study

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic mastocytosis
    Investigated Drugs:
    • Avapritinib
    Belgium France Germany Italy The Netherlands Norway +2

  • Study of Dapansutrile and Paracetamol for Patients with Acute Gout Flare

    Recruiting

    4 1 1
    Investigated Drugs:
    • Dapansutrile
    • Paracetamol
    France The Netherlands Spain

  • Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    Investigated Drugs:
    • Lomustine
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Denmark Finland Germany +4

  • Study on Valproic Acid, Simvastatin, and Gemcitabine for Untreated Metastatic Pancreatic Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Simvastatin
    • Valproic Acid
    • Capecitabine
    Italy Spain

  • Study on CART 19/22 T Cells and CART45RA-NKG2D Cells for Treating Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents, and Young Adults

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Cart 19/22 T Cells
    • Cart45Ra-Nkg2D Cells
    Spain
Previous Page
1 … 650 651 652 653 654 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!